Novanta Inc. (NOVT)
| Market Cap | 5.45B |
| Revenue (ttm) | 796.26M |
| Net Income (ttm) | 63.66M |
| Shares Out | 35.64M |
| EPS (ttm) | 1.78 |
| PE Ratio | 85.96 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 171,657 |
| Open | 150.73 |
| Previous Close | 151.28 |
| Day's Range | 150.73 - 153.62 |
| 52-Week Range | 110.84 - 184.44 |
| Beta | 1.16 |
| Analysts | Buy |
| Price Target | 145.52 (-4.9%) |
| Earnings Date | Aug 9, 2022 |
About NOVT
Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequen... [Read more...]
Financial Performance
In 2021, Novanta's revenue was $706.79 million, an increase of 19.67% compared to the previous year's $590.62 million. Earnings were $50.33 million, an increase of 13.05%.
Financial StatementsAnalyst Forecast
According to 10 analysts, the average rating for NOVT stock is "Buy." The 12-month stock price forecast is 145.52, which is a decrease of -4.89% from the latest price.
News
Novanta (NOVT) Q2 Earnings and Revenues Beat Estimates
Novanta (NOVT) delivered earnings and revenue surprises of 8.33% and 3.19%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Novanta Announces Financial Results for the Second Quarter 2022
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results fo...
Novanta (NOVT) Moves 9.6% Higher: Will This Strength Last?
Novanta (NOVT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in th...
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 9, 2022
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second quarter 202...
Novanta to Present at the CJS Securities 22nd Annual “New Ideas” Summer Conference on Tuesday, July 12, 2022
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glast...
Novanta to Present at Baird's 2022 Global Consumer, Technology & Services Conference on Tuesday, June 7, 2022
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley...
Novanta to Present at the William Blair 42nd Annual Growth Stock Conference on Monday, June 6, 2022
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley...
Novanta Announces Financial Results for the First Quarter 2022
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results fo...
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 10, 2022
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2022...
Novanta (NOVT) Soars 7.1%: Is Further Upside Left in the Stock?
Novanta (NOVT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Novanta (NOVT) Surpasses Q4 Earnings and Revenue Estimates
Novanta (NOVT) delivered earnings and revenue surprises of 6.35% and 4.55%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2021
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financi...
Novanta Partners with MassRobotics to Advance Next Generation of Robotics
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Partners with MassRobotics to Advance Next Generation of Robotics
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, March 01, 2022
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth quarter and...
Novanta to Present at the CJS Securities 22nd Annual New Ideas for the New Year Investor Conference on Wednesday, Jan...
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley...
Novanta to Present at the J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastr...
Novanta (NOVT) Surpasses Q3 Earnings and Revenue Estimates
Novanta (NOVT) delivered earnings and revenue surprises of 22.95% and 2.61%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Novanta Announces Financial Results for the Third Quarter 2021
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq:NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for...
Novanta (NOVT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Novanta (NOVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Novanta to Present at Baird's 2021 Global Industrial Conference on Wednesday, November 10, 2021
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastr...
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 09, 2021
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2021...
Novanta (NOVT) Moves 4.2% Higher: Will This Strength Last?
Novanta (NOVT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down...
All You Need to Know About Novanta (NOVT) Rating Upgrade to Strong Buy
Novanta (NOVT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Top Ranked Momentum Stocks to Buy for September 3rd
PVH, WTS, SCSC, and NOVT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 3, 2021
Novanta to Present at Baird's 2021 Global Healthcare Conference on Wednesday, September 15, 2021
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glast...